Newstral
Article
journalrecord.com on 2022-11-01 23:07
Pfizer rides Paxlovid sales to better-than-expected quarter
Related news
- Pfizer rides Paxlovid sales to better-than-expected quarterSeattle Times
- Domino’s Pizza delivers better-than-expected fourth quarterseattletimes.com
- MVisa shares gain on better-than-expected fourth-quarter earningsmarketwatch.com
- MAeroVironment shares surge on better-than-expected quartermarketwatch.com
- Walmart reports better-than expected second-quarter resultsnwaonline.com
- Coca-Cola fourth-quarter sales better than expected despite lower US demandShropshire Star
- Mounjaro, Zepbound pour money into Eli Lilly, fueling a better-than-expected second quarterseattletimes.com
- IPaychex reports better than expected profit in the fiscal third quarterinvezz.com
- MCuraleaf's strong quarter sets it up for a better-than-expected year -- and that's without sales in New York and New Jerseymarketwatch.com
- Biopharmaceuticals power Pfizer in the first quarterSeattle Times
- Covid-19 Vaccine From Pfizer, BioNTech Works Better Than Expectedwsj.com
- BPagerDuty Stock Slides Despite Better-Than-Expected Fourth-Quarter Salesbarrons.com
- Teva Surprises With Better-than-expected First QuarterHaaretz
- BSnowflake's Stock Remains Volatile After a Better-Than-Expected Quarterbarrons.com
- IChewy reports better than expected earnings for the first quarterinvezz.com
- NNordstrom reports better-than-expected first quarter profitsnypost.com
- MBoston Scientific reports better-than-expected sales during third quartermarketwatch.com